Neurokinin‐1 receptor antagonists for prevention of chemotherapy‐related nausea and vomiting in adults
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
-
To assess the effectiveness of NK1 receptor antagonists in controlling acute and delayed nausea and vomiting in participants on moderate and highly emetogenic chemotherapy.
-
To determine the adverse events associated with NK1 receptor antagonists in participants receiving these drugs.
-
To assess the effect that NK1 receptor antagonists have had on the quality of life of participants treated with moderate and highly emetogenic chemotherapy.